Follow the 진원생명과학 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 진원생명과학 has recorded 6 reports. Market capitalisation: €9.7bn. The latest transaction was disclosed on 29 June 2026 (Sale). Among the most active insiders: 진원생명과학. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Jinwon Life Science is a company specializing in the health and pharmaceutical sector. It is listed on the XKRX market.